Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Shares Outstanding (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Shares Outstanding for 12 consecutive years, with $8.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 2.15% year-over-year to $8.9 million, compared with a TTM value of $8.9 million through Sep 2025, up 2.15%, and an annual FY2024 reading of $8.8 million, up 2.56% over the prior year.
  • Shares Outstanding was $8.9 million for Q3 2025 at Sanara MedTech, roughly flat from $8.9 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $8.9 million in Q3 2025 and bottomed at $7.6 million in Q2 2021.
  • Average Shares Outstanding over 5 years is $8.3 million, with a median of $8.4 million recorded in 2023.
  • The sharpest move saw Shares Outstanding increased 22.78% in 2021, then rose 1.79% in 2025.
  • Year by year, Shares Outstanding stood at $7.7 million in 2021, then grew by 8.12% to $8.3 million in 2022, then increased by 2.83% to $8.5 million in 2023, then grew by 2.56% to $8.8 million in 2024, then grew by 2.02% to $8.9 million in 2025.
  • Business Quant data shows Shares Outstanding for SMTI at $8.9 million in Q3 2025, $8.9 million in Q2 2025, and $8.9 million in Q1 2025.